Breaking News

U.S.-Georgia Bilateral Defense Consultations > U.S. Department of Defense > Release Federal court agrees with Kansas, blocks Biden administration from lifting Title 42 immigration policy El Paso Area CBP Officers Seize Narcotics Flag Officer Announcement > U.S. Department of Defense > Release Governor Abbott Statement On Federal Court Keeping Title 42 Expulsions | Office of the Texas Governor Robinson takes reins at AETC > Air Force > Article Display Air and Marine Agents Alongside Law Enforcement and Fire Service Partners Rescued a Recreational Boater as His Vessel Sunk Spend Your FEMA Grant Wisely and Only on Disaster-Related Expenses

April 27, 2022 – GATINEAU, QC – Competition Bureau

A Competition Bureau investigation concluded that NuvoCare Health Sciences Inc. and founder, Ryan Foley, made marketing claims that gave the false or misleading impression that their products have been proven to cause weight loss. The Bureau found that their claims were not supported by adequate and proper testing.

The Bureau resolved its concerns through a consent agreement reached with NuvoCare and Ryan Foley, that will prevent both from making false, misleading or unsupported marketing claims to consumers about products they market for weight loss.  

As part of this settlement, NuvoCare and Ryan Foley agreed to:

  • pay $100,000 in total penalties
  • change or remove all weight loss claims made about their products
  • establish and maintain a corporate compliance program to promote compliance with the law and prevent deceptive marketing issues in the future

NuvoCare’s claims promoted the WeightOFF Max!, Forskolin+ and Forskolin Nx, among other products, and were made on labels and packaging, web platforms, social media, magazines, emails and at expos.

NuvoCare’s products are licenced by Health Canada to make certain claims, but not to make weight loss claims.

The settlement registered with the Competition Tribunal has the force of a court order and will be binding for a period of 10 years.

Source link